Dlulela kwisiqulatho
I-Parkinson yamazwe ngamazwe kunye ne-Movement Disorder Society

 

IQela loFundo lwe-Progressive Supranuclear Palsy (PSP).

Ngena ngoku

Ngaba unemibuzo? Nxibelelana noSarah Smith, uMnxibelelanisi wabasebenzi be-MDS beqela, kule dilesi ssmith@movementdisorders.org

imvelaphi

I-Progressive Supranuclear Palsy (PSP) ngumntu omdala-ukuqala kwe-neurodeergenerative disorder kunye ne-cerebral 4R-tau pathology ekhokelela kwi-akinetic-rigid syndrome ene-oculomotor dysfunction, ukungazinzi kwe-postural, i-lobe yangaphambili kunye nokungasebenzi kakuhle kwe-bulbar. Iqela lophononongo lwe-PSP nalo linomdla osebenzayo wokuwohloka kwe-corticobasal (CBD). Iikhrayitheriya ezintsha zophando zokuvumelana zisanda kupapashwa ukuququzelela izifundo ze-CBD (Armstrong, et al. Neurology 2013; 80: 496-503). Njenge-PSP, i-CBD yi-primary four repeat (4R) i-tauopathy enezixhumanisi ezinamandla zofuzo kwi-tau gene (MAPT). Ngenxa yokuba i-CBD ye-pathological ihlala idlula kunye ne-PSP yekliniki, kwaye ngokuphambeneyo, zombini iziphazamiso zihlala ziqwalaselwa ngokufanayo, ngakumbi kwizifundo ze-biomarker kunye ne-imaging. Njengoko unyango oluthile olujoliswe kwi-tau luphuhliswa kwi-PSP, kuqikelelwa ukuba ii-arhente ezinjalo zinokuba luncedo ekuphatheni i-CBD, mhlawumbi ekhokelela kwizilingo zeklinikhi ezidibeneyo kuzo zombini izifo.

Akukho zikhetho zonyango lonyango lwe-PSP kunye ne-CBD zikhoyo ngoku. Uphando lweklinikhi kwezi ziphazamiso zinqabileyo zilinganiselwe ngamandla ngenxa yokuqhekeka kwayo.

Injongo yethu iyonke kukukhuthaza uphando lokuphucula iindlela zokuxilonga kunye nonyango lwe-PSP kunye ne-CBD. Ngokukodwa, sijolise ekuphuculeni ukuxilongwa kwangaphambili kwe-PSP kunye ne-CBD, ukudala uthungelwano lophando lweklinikhi, kunye nokuququzelela izilingo zonyango zonyango kwi-PSP kunye ne-CBD.

 

Iiprojekthi zangoku

Vula konkeVala konke
1. Ukuphucula ukuxilongwa kwekliniki ye-PSP kunye ne-CBD

Umgangatho wegolide wokuxilonga ukuxilongwa kwe-pathological (Hauw et al., Neurology. 1994; 44: 2015-9). Ukuxilongwa kweklinikhi kuhlala kungumngeni. I-National Institute of Neurological Disorders kunye ne-Stroke kunye ne-Society for PSP (NINDS-SPSP) iikhrayitheriya ziye zacetywa ukuxilongwa kwekliniki (Litvan et al., Neurology 1996; 46: 922-930). Ukuqinisekiswa kwezi migaqo kwiiseti ezizimeleyo zezigulane zibonise ixabiso eliphezulu eliqikelelweyo, nangona uvakalelo oluphantsi ngokukodwa ngexesha lekhosi yokuqala yesifo kunye neentetho zeklinikhi ezihlukeneyo (Osaki et al., Mov Disord. 2004; 19; 181-189; Respondek et al., Mov Disord. 2013 do. Ngokukodwa, iikhrayitheriya ze-NINDS-SPSP azizange zivumele ukuqatshelwa kweenkcazo ezichazwe kutshanje ze-phenotypic phenotypic PSP kunye nokubonakaliswa kweklinikhi kwasekuqaleni.

Inkalo ebaluleke kakhulu yi-diagnostic diagnostic vs. corticobasal degeneration (CBD).

Ngoko ke, iqela lesifundo se-MDS-PSP liseke iindlela ezintsha ze-MDS zokuxilongwa kwe-PSP ngokwesiseko sovavanyo olucwangcisiweyo lwamanqaku ophando ashicilelweyo angaphezu kwama-6000 kunye nentlanganiso egxile kwisivumelwano kunye neengcali zamazwe ngamazwe ezingama-40 (uHöglinger et al., zeQela leSifundo se-PSP elivunyiwe yiMovement Disorder Society. Ukuxilongwa kweKlinikhi kweProgressive Supranuclear Palsy - Iikhrayitheriya zeMovement Disorder Society. Iingxaki zeMovement, 2017;32(6):853-864.

Ukuqinisekiswa kweekhrayitheriya ze-MDS-PSP kwiimeko ezizimeleyo zeklinikhi-pathological kuyaqhubeka.

Ukuqinisekiswa kwentsebenziswano okulindelweyo kwenkqubo ye-MDS-PSP nako kuyaqhubeka (jonga injongo yesi-2).

2. Ukukhuthaza uphando lwezonyango lwentsebenziswano kwi-PSP kunye ne-CBD

Sijonge ukudala uthungelwano lophando lweklinikhi ukuphucula umgangatho wedatha yembali yendalo yeklinikhi, idatha ye-neuroimaging kunye ne-biomaterials. Ke ngoko, iinethiwekhi zophando lweklinikhi ziye zaqaliswa

  • France (NS-PARK/FCRIN network PIs: Jean-Christoph Corvol, Olivier Rascol)

  • EJamani (Chaza-PSP / iziFundo zeProPSP: PI: Günter Höglinger)
  • I-Italiya (iRegistry ye-PSP yase-Italian: PIs: Paolo Barone / Angelo Antonini)
  • Japan (JALPAC Study, PI: Takahiko Tokuda, Ikuko Aiba, Kenji Nakashima)
  • UK (PROSPECT-UK Study, PI: Huw Morris)
  • USA (4RTNI / ARTFL Studies, PI: Adam Boxer)

Siqhubeleka neenzame zethu zokungqinelanisa iiprothokholi zezifundo zeqela lesizwe ukwandisa iziphumo zenzululwazi. Kukho imfuneko ethile yokuvelisa idatha yembali yendalo yeendlela ezahlukeneyo zokubonakaliswa kwekliniki ye-PSP, njengoko iqhutywe ngoku okokuqala kwiikhrayitheriya ze-MDS-PSP, njengesiseko sezilingo zonyango ezizayo.

3: Ukukhuthaza ulingo lweklinikhi olujolise ukunyanga i-PSP kunye ne-CBD

Iinketho zonyango ezikhoyo ngoku zilinganiselwe kungenelelo lweempawu kunye nokusebenza okuphantsi. Akukho ndlela yonyango yokhuselo okanye yonyango ekhoyo ngoku. Ke ngoko, sijonge ukuqalisa imilinganiselo yokuququzelela izilingo zonyango zonyango kwi-PSP.

Isayensi esisiseko iyaqhubeka nokuchonga iithagethi zeemolekyuli kunye nongenelelo oluhambelanayo. Ukuguqulelwa kulingo lweklinikhi ukuvavanya ukhuseleko kunye nokusebenza kwabo kusemva. Izizathu ke ngoko zilele ngokuyinxenye kuluhlu olunyiniweyo loyilo lophononongo olungqale kwi-PSP. Ngenxa yale njongo kufuneka siphuhlise kwaye sisebenzise amanqaku ezonyango kunye nezikali ukuze silinganise iimpawu ezijoliswe kwisifo esithile, kunye nokuchonga iimpawu ezihambelana nokunyuka kwesifo. Ukufunyanwa kwedatha yembali yendalo efunekayo ekubaleni amandla kunzima ngakumbi kwi-PSP ngenxa yobubanzi bayo bezonyango, ukungabikho kweenqobo zolwahlulo oluqhelekileyo olwamkelweyo lwezonyango, kunye nokwahlulwa ngokwejografi kuphando lwezonyango.

Iqela lophononongo lwe-MDS-PSP lithatha inxaxheba esebenzayo ekwandiseni indlela yolingo lwezonyango, umz

  • Stamelou M, Schöpe J, Wagenpfeil S, del Ser T, Antonelou RCh, Oertel WH, Boxer AL, Höglinger GU. Ukubala kwamandla kunye ne-Placebo Effect Estimation for Clinical Trials kwi-Progressive Supranuclear Palsy. Ukuphazamiseka kweMovement, 2016; 31 (5): 742-7.
  • Höglinger GU, Schöpe J, Stamelou M., Kassubek J., Del Ser T, Boxer AL, Wagenpfeil S, Huppertz HJ, Longitudinal MRI volumetry njengokufundwa kwezilingo zeklinikhi kwi-progressive supranuclear palsy: amanqaku amatsha adibeneyo. Iziphazamiso zokuhamba. 2017;32(6):842-852.

Amalungu eqela lophononongo lwe-MDS-PSP abonakalise ubuchwephesha bokuqhuba ngokuchubekileyo ulingo lwezonyango kwi-PSP, umz.:

  • Stamelou M, Reuss A, Pilatus U, Magerkurth J, Niklowitz P, Eggert KM, Krisp A, Menke T, Schade-Brittinger C, Oertel WH, Höglinger GU. Iziphumo zexesha elifutshane ze-coenzyme Q10 kwi-progressive supranuclear palsy: uvavanyo olungahleliwe, olulawulwa yi-placebo. Ukuphazamiseka kweMovement, 2008; 23: 942-9.
  • Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T; TAUROS Abaphandi. Ulingo lwesigaba sesi-2 se-GSK-3 inhibitor tideglusib kwi-progressive supranuclear palsy. Mov Disord. 2014 Epreli;29(4):470-8.
  • Höglinger GU, Huppertz HJ, Wagenpfeil S, Andrés MV, Belloch V, León T, Del Ser T; TAUROS MRI Abaphandi. I-Tideglusib yehlisa ukuqhubela phambili kwe-atrophy yobuchopho kwi-progressive supranuclear palsy kulingo olungenamkhethe. Mov Disord. 2014 Epreli;29(4):479-87.
  • I-Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler JCR M, Rando Dech, Van Dechr, Koestler JCR, van Deach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH; AL-108-231 Abaphandi. I-Davunetide kwizigulane ezine-progressive supranuclear palsy: i-randomised, i-double-blind, i-placebo-controlled controlled phase 2/3. I-Lancet Neurol. 2014 Jul;13(7):676-85.

Ngaloo ndlela, amalungu eqela lokufunda le-MDS-PSP abandakanyeka ngokukhutheleyo ekucwangciseni nasekuqhubeni ulingo lwesigaba II/III ngongenelelo olujoliswe kwi-tau.

4: Ukusasaza ulwazi malunga ne-PSP kunye ne-CBD

Icandelo laseYurophu leqela lenze i-Continuing Medical Education Course 'iminyaka eyi-50 ye-Progressive Supranuclear Palsy' ngo-Oktobha 2014 eMunich. Ngenxa yomdla ophezulu kunye neempendulo ezilungileyo, sijonge ukulungiselela ikhosi yesibini ka-2019.

Iqela lijolise ekulungiseleleni isixhobo sewebhusayithi kunye nesifundo esisekelwe kwividiyo ekuphunyezweni okubanzi kwendlela entsha yokuxilonga i-MDS kwindlela yeklinikhi.

Isishwankathelo, iQela lokufunda le-MDS le-PSP liseke izifundo kunye namanyathelo okuphucula ulwazi, ukuxilongwa kwangaphambili kunye nonyango lwe-PSP kunye ne-CBD.

IQela loFundo lwe-PSP ladibana eMunich, eJamani, ngoMatshi ka-2016.IQela lokufunda le-PSP eMunich, eJamani, ngoMatshi ka-2016

ubunkokheli


Sihlalo

Ewe Morris 

 

 

UMaria Stamelou
Sihlalo
Gabor Kovacs

 


Sihlalo
Yaroslau Compta 

Ikomiti eqhubayo

UAdam Boxer
UAlex Pantelyat

Angelo Antonini

U-Anne-Marie Wills

U-Ed Jabbari
U-Elise Dopper
UGunther Hoeglinger

Ikuko Aiba

Irene Litvan
Jacky Ganguly

UJennifer Whitwell

Kigocha Okeng'o

Nesrine Kouki

Prashanth L. Kukkle

UShelley Forrest

UStefan Lorenzl

Iqela elidibeneyo

Nceda ulinde ngelixa siqokelela iziphumo zakho.

Amaphepha apapashiweyo

I-Progressive Supranuclear Palsy-Uphononongo lweGlobal

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

I-18F-PI-2620 i-Tau PET iphucula uFundo lweMifanekiso ye-Progressive Supranuclear Palsy

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Ixesha elide iProgressive Supranuclear Palsy: Ikhosi yeklinikhi kunye nePathological Underpinnings

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Iikhrayitheriya zoMbutho we-Movement Disorder for the Diagnosis of Multiple System Atrophy

Iqela elidibeneyo
  • Multirogram System Atrophy
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Iipateni zokubeka iTau zinxulunyaniswa noqhagamshelo olusebenzayo kwii-tauopathies eziphambili

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

I-Progressive Supranuclear Palsy Clinical Deficits Scale

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Ukuqinisekiswa koMbutho we-Movement Disorder Society Criteria ye-Diagnostic of 4-Repeat Tauopathies

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Zeziphi iimpawu ze-ante-mortem eziqikelela i-progressive supranuclear palsy?

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Iimpawu ze-radiological biomarkers zokuxilongwa kwi-PSP: Siphi kwaye kufuneka sibe phi?

Iqela elidibeneyo
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

Izikali zokuvavanya iimpawu zeklinikhi ze-progressive supranuclear palsy: Ingxelo ye-MDS Task Force

Iqela elidibeneyo
  • UVavanyo lweZiphumo zoNyango / Izikali zokuReyitha
  • Inkqubela phambili yokuHamba kwePransukraine (PP)

 

UVimba weProjekthi

Izifundo ezidlulileyo

Iminyaka engama-50 yeProgressive Supranuclear Palsy
IMunich, eJamani
Oktobha 10-11, 2014